Global Complement Protein C5 Inhibitors Industry Growth and Trends Forecast to 2032

Types

• Subcutaneous Administration
• Oral Administration
• Intravenous Injection

Applications

• Geographic Atrophy (GA)
• Atypical Hemolytic Uremic Syndrome (aHUS)
• Neuromyelitis Optica Spectrum Disorde (NMOSD)
• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Others

Key Companies